MARKET

GNMK

GNMK

GenMark
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.190
+0.070
+1.70%
After Hours: 4.220 +0.03 +0.72% 19:33 04/01 EDT
OPEN
4.060
PREV CLOSE
4.120
HIGH
4.190
LOW
3.930
VOLUME
1.22M
TURNOVER
--
52 WEEK HIGH
8.17
52 WEEK LOW
3.360
MARKET CAP
254.65M
P/E (TTM)
-5.0905
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average GNMK stock price target is 9.75 with a high estimate of 11.00 and a low estimate of 8.00.

EPS

GNMK News

More
  • Penny Stocks to Watch for April 2020
  • Investopedia · 2d ago
  • Genmark Diagnostics nabs BARDA contract to develop respiratory pathogen panel
  • seekingalpha · 03/24 00:55
  • GenMark Awarded BARDA Grant for the Development of ePlex® RP2 Panel
  • GlobeNewswire · 03/24 00:45
  • Is the Options Market Predicting a Spike in GenMark (GNMK) Stock?
  • Zacks · 03/23 14:31

Industry

Advanced Medical Equipment & Technology
-5.26%
Healthcare Equipment & Supplies
-4.98%

Hot Stocks

Symbol
Price
%Change

About GNMK

GenMark Diagnostics, Inc. is a molecular diagnostics company. The Company is focused on developing and commercializing multiplex molecular tests that aid in the diagnosis of complex medical conditions. It develops and commercializes multiplex molecular tests based on its eSensor electrochemical detection technology. It offers four Food and Drug Administration (FDA)-cleared diagnostic tests which run on its XT-8 instrument; its Respiratory Viral Panel; its Cystic Fibrosis Genotyping Test; its Warfarin Sensitivity Test, and its Thrombophilia Risk Test. It also offers a Hepatitis C (HCV) genotyping test and associated custom manufactured reagents, as well as a 2C19 Genotyping Test, versions of which are available for use with its XT-8 instrument for research use only (RUO). Its XT-8 and ePlex test cartridges utilize the combination of distinct electrodes and multiple signal probes to detect dozens of target biomarkers from a single sample, thereby enabling highly multiplexed testing.
More

Webull offers kinds of GenMark Diagnostics, Inc stock information, including NASDAQ:GNMK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GNMK stock news, and many more online research tools to help you make informed decisions.